Search
Kura Oncology Inc
KURAAdd to Watchlist
11.100USD
+0.320+2.97%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
985.27MMarket Cap
LossP/E TTM
Kura Oncology Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
67.48M
25.24%
EPS(YoY)
-3.18
-57.40%
Analyst Rating
BUY
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its total revenue reached 67.48M, with a year-on-year change of 25.24.
What are the current assets of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its current assets were 708.66M, with a year-on-year change of -4.86.
What are the total assets of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its total assets of Kura Oncology Inc were 738.36M, with a year-on-year change of -2.87.
What are the total liabilities of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its total liabilities of Kura Oncology Inc were 564.23M, with a year-on-year change of 62.83.
What is the total equity of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its total equity of Kura Oncology Inc was 174.13M, with a year-on-year change of -57.90.
What is the net investment of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its net investment of Kura Oncology Inc was -13.10M, with a year-on-year change of 87.11.
What is the net financing of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its net financing of Kura Oncology Inc was 1.79M, with a year-on-year change of -98.84.
What is the Earnings Per Share (EPS) of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.18, with a year-on-year change of -57.40.
What is the net margin of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its net profit margin was -412.95, with a year-on-year change of -27.89.
What is the gross margin of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its gross margin was 99.92, with a year-on-year change of -0.08.
What is the debt-to-asset ratio of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its debt-to-asset ratio was 1.32, with a year-on-year change of 4.98.
What is the Return on Equity (ROE) of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its Return on Equity (ROE) was -94.82, with a year-on-year change of -120.97.
What is the Return on Assets (ROA) of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its Return on Assets (ROA) was -37.19, with a year-on-year change of -29.23.
What is the operating profit of Kura Oncology Inc?
According to Kura Oncology Inc's FY2025 earnings report, its operating profit was -303.63M, with a year-on-year change of -57.16.